Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MuST

Financiado

On-chip model of mucociliary clearance for the design of drug formulations aimed...

On-chip model of mucociliary clearance for the design of drug formulations aimed at chronic respiratory diseases Chronic respiratory diseases (CRDs) caused 4 million deaths worldwide in 2019. CRD treatments are often administered by inhalation in particulate formulations. However, mucociliary clearance (MCC) acts as an effective physical bar... ver más

30/06/2026

UPCité

196K€

Presupuesto del proyecto: 196K€

Líder del proyecto

UNIVERSITE PARIS CITE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-05-16

HORIZON-MSCA-2023-PF-01-01: MSCA Postdoctoral Fellowships 2023 ExpectedOutcome:Project results are expected to contribute to the following outcomes:

I+D

Cerrada hace 1 año

0% 100%

1 Participantes

UPCité

195.91K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PCI2024-153423 Herramientas diagnósticas, pronósticas y terapéuticas 315K€ Cerrado

MUC2GO Novel treatments for the mucus accumulation at chronic lung... 150K€ Cerrado

RTC-2017-6643-1 USO DE FORMULACIONES POLIMÉRICAS MUCOADHESIVAS PARA LA ERRAD... 194K€ Cerrado

AcouSome Acoustofluidic thin-film actuated chip for exosome separatio... 2M€ Cerrado

SYNEBIO High-throughput combinatory drugs testing on in vitro 3D cel... 150K€ Cerrado

BIO2015-67930-R EXPLO(R+T)ANDO EL MARCO BIOTECNOLOGICO DE LA LANZADERA SURFA... 387K€ Cerrado

Duración del proyecto: 25 meses Fecha Inicio: 2024-05-16
Fecha Fin: 2026-06-30

Líder del proyecto

UNIVERSITE PARIS CITE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 196K€

Descripción del proyecto Chronic respiratory diseases (CRDs) caused 4 million deaths worldwide in 2019. CRD treatments are often administered by inhalation in particulate formulations. However, mucociliary clearance (MCC) acts as an effective physical barrier that prevents drugs from reaching the target cells. This mechanism relies on the beating of cilia on the bronchi surface, which allows the displacement of the overlying mucus layer. Inhaled drugs are thus trapped by the mucus and quickly evacuated from the airways. The objective of the MuST project is to model the mechanism of MCC using a microfluidic chip, to assess drug penetration through the moving mucus and thus provide a screening platform for new drug formulations. Our main objective can be subdivided into three research objectives: 1) Develop an adequate synthetic mucus model; 2) Reproduce the mucociliary clearance mechanism on a microfluidic chip; 3) Screen innovative drug formulations using our chip. In this project, we combine expertise in biophysics, physical chemistry, soft condensed matter, and nanomedicine. The originality of our approach lies in 3 key aspects: 1) We will develop a synthetic mucus model that reproduces all the properties of native human mucus; 2) We choose to design a non-cellular MCC model, which will provide an easy, quick, cheap, and reproducible alternative to cell-based MCC models; 3) We will apply an original technique called differential dynamic microscopy (DDM) to characterize the drug behaviour in the chip. DDM is perfectly adapted to measure particle diffusion in biological hydrogels under flowing conditions. Our innovative screening platform will pave the way to design more efficient formulations to treat CRDs, with higher delivery rates, thereby improving the available treatments and lowering their costs. This project is in line with the United Nations’ aim to reduce by 2030 by one-third premature mortality from non-communicable diseases [including CRDs] through prevention and treatment.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores